News-Medical.Net on MSN
Medicaid Tries New Approach With Sickle Cell: Companies Get Paid Only If Costly Gene Therapies Work
Serenity Cole enjoyed Christmas last month relaxing with her family near her St. Louis home, making crafts and visiting friends. It was a contrast to how Cole, 18, spent part of the 2024 holiday ...
A new gene therapy for people who can have a stem cell transplant but do not have a suitable donor has been approved.
NHS Scotland has approved a one-time CRISPR gene therapy for severe sickle cell disease, offering durable reduction in vaso-occlusive crises for eligible patients.
Hoosiers from across the state will gather at the Indiana State Capitol on Monday, Feb. 2, to call attention to the urgent ...
CS-101 is Shanghai-based CorrectSequence's lead candidate, which it is developing for treating sickle-cell disease and ...
Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...
GLP-1 receptor agonist use appeared linked to significantly reduced all-cause mortality among people with sickle cell disease ...
Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle ...
Please provide your email address to receive an email when new articles are posted on . Researchers observed what they called “alarming” underutilization of disease-modifying therapies for sickle cell ...
WESTLAND, Mich. — For D’Asia Jackson, every day is a guessing game over whether excruciating pain will upend her life. The 28-year-old medical assistant was born with sickle cell disease, an inherited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results